NDRG1 and glioblastoma: Furthermore, we found that high expressions of NDRG1 [94], CDH1 [78], ERRFI1 [72, 95], G6PD [96], and ZKSCAN3 [29, 32] were significantly correlated with better prognosis of GBM patients and longer overall survival.